Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis.

Parasramka MA, Dashwood WM, Wang R, Saeed HH, Williams DE, Ho E, Dashwood RH.

Clin Epigenetics. 2012 Sep 24;4(1):16. doi: 10.1186/1868-7083-4-16.

PMID:
23006636
[PubMed]
Free PMC Article
2.

Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.

Fu J, Tang W, Du P, Wang G, Chen W, Li J, Zhu Y, Gao J, Cui L.

BMC Syst Biol. 2012 Jun 15;6:68. doi: 10.1186/1752-0509-6-68.

PMID:
22703586
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
[PubMed - indexed for MEDLINE]
4.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

PMID:
19843336
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer.

Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI.

Neoplasia. 2012 Sep;14(9):868-79.

PMID:
23019418
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Target identification of microRNAs expressed highly in human embryonic stem cells.

Li SS, Yu SL, Kao LP, Tsai ZY, Singh S, Chen BZ, Ho BC, Liu YH, Yang PC.

J Cell Biochem. 2009 Apr 15;106(6):1020-30. doi: 10.1002/jcb.22084.

PMID:
19229866
[PubMed - indexed for MEDLINE]
7.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
[PubMed - indexed for MEDLINE]
8.

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.

Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P; COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Ørntoft TF, Andersen CL.

Int J Cancer. 2013 Jul;133(1):67-78. doi: 10.1002/ijc.28010. Epub 2013 Feb 12.

PMID:
23280316
[PubMed - indexed for MEDLINE]
9.

Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states.

Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM, Subramanian S, Wang L, Smyrk TC, Rodrigues CM, Thibodeau SN, Steer CJ.

BMC Cancer. 2009 Nov 18;9:401. doi: 10.1186/1471-2407-9-401.

PMID:
19922656
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.

Breast Cancer Res. 2012 May 14;14(3):R77.

PMID:
22583478
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.

He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J.

Mol Med. 2013 Feb 8;18:1491-8. doi: 10.2119/molmed.2012.00304.

PMID:
23255074
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.

Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L, Esposito S, Gargiulo S, Fattet S, Donofrio V, Cinalli G, Brunetti A, Vecchio LD, Northcott PA, Delattre O, Taylor MD, Iolascon A, Zollo M.

PLoS One. 2009;4(3):e4998. doi: 10.1371/journal.pone.0004998. Epub 2009 Mar 24.

PMID:
19308264
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H.

Oncotarget. 2012 Jan;3(1):44-57.

PMID:
22294552
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.

Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL.

Oncogene. 2012 May 31;31(22):2750-60. doi: 10.1038/onc.2011.453. Epub 2011 Oct 3.

PMID:
21963845
[PubMed - indexed for MEDLINE]
15.

The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.

Xu RS, Wu XD, Zhang SQ, Li CF, Yang L, Li DD, Zhang BG, Zhang Y, Jin JP, Zhang B.

Int J Oncol. 2013 Feb;42(2):676-82. doi: 10.3892/ijo.2012.1746. Epub 2012 Dec 20.

PMID:
23258531
[PubMed - indexed for MEDLINE]
16.

An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.

Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, Jiang C, Dai Y, Guo X, Xiang J, Li G.

BMC Med Genomics. 2012 Jan 19;5:3. doi: 10.1186/1755-8794-5-3.

PMID:
22260379
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.

Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C.

World J Surg. 2009 Apr;33(4):698-709. doi: 10.1007/s00268-008-9833-0. Review.

PMID:
19030927
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.

Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zöllner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA.

Carcinogenesis. 2012 Apr;33(4):732-9. doi: 10.1093/carcin/bgs020. Epub 2012 Jan 27.

PMID:
22287560
[PubMed - indexed for MEDLINE]
Free Article
19.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
[PubMed - indexed for MEDLINE]
20.

Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.

Wang XY, Wu MH, Liu F, Li Y, Li N, Li GY, Shen SR.

Mol Cell Biochem. 2010 Dec;345(1-2):283-90. doi: 10.1007/s11010-010-0582-7. Epub 2010 Sep 22.

PMID:
20859756
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk